evidation.comHealthcare / Digital HealthFounded: 2012Funding to Date: $625.08MM
Evidation is a healthcare discovery company measures health in everyday life and enables anyone to participate in groundbreaking research and health programs.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/23/2024 | Series E-2 | $105MM | $xx.xx | $1.11B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,671,659
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/22/2021 | Series E | $153MM | $xx.xx | $1B | B Capital Group, Mckesson Ventures, Omers Growth Equity, Permanente Group Trust | |
Price per Share
$xx.xx
Shares Outstanding
8,264,416
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
B Capital Group, Mckesson Ventures, Omers Growth Equity, Permanente Group Trust
|
||||||
07/01/2020 | Series D | $45MM | $xx.xx | $327.81MM | B Capital Group, Mckesson Ventures, Rethink Impact, Revelation Partners, Section 32, Sv Health Investors | |
Price per Share
$xx.xx
Shares Outstanding
6,386,328
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
B Capital Group, Mckesson Ventures, Rethink Impact, Revelation Partners, Section 32, Sv Health Investors
|
||||||
08/01/2018 | Series C | $30MM | $xx.xx | $217.99MM | B Capital Group, Ge Ventures, Sanofi Ventures, Sv Health Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,925,221
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
B Capital Group, Ge Ventures, Sanofi Ventures, Sv Health Investors
|
||||||
04/27/2017 | Series B-1 | $10MM | $xx.xx | $100.67MM | B Capital Group, Ge Ventures, Sanofi | |
Price per Share
$xx.xx
Shares Outstanding
3,874,616
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
B Capital Group, Ge Ventures, Sanofi
|
||||||
10/11/2016 | Series B | $15.5MM | $xx.xx | $88.76MM | Amv, B Capital Group, Fresco Capital, Ge Ventures, Pappas Ventures | |
Price per Share
$xx.xx
Shares Outstanding
6,826,088
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Amv, B Capital Group, Fresco Capital, Ge Ventures, Pappas Ventures
|
||||||
01/16/2015 | Series A | $6.54MM | $xx.xx | $32.7MM | Amv, Fresco Capital, Ge Ventures | |
Price per Share
$xx.xx
Shares Outstanding
4,901,329
Liquidation Pref Order
6
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Amv, Fresco Capital, Ge Ventures
|